Mental health in adolescents with obesity: conflicting views among physicians, a qualitative study.

Mental health issues in adolescents with obesity are multifold, with no explicit screening recommendations. The aim of this research is to explore how this screening is performed by physicians and, thus, how it impacts adolescents' care pathways, offering insights into how to improve it through a qualitative study using interpretative phenomenological analysis. Twenty physicians (non-psychiatrist physicians and child and adolescent psychiatrists) involved at various stages in the care pathway were interviewed with semi-structured questionnaires. The findings connect 2 meta-themes. Non-psychiatrist physicians perceive widespread but ill-defined suffering in adolescents with obesity. Non-psychiatrist physicians see screening for mental conditions as mandatory. Unlike child and adolescent psychiatrists, they are not experts in distinguishing psychosocial suffering from psychiatric disorders. Screening is clinical. Adolescents' demand to lose weight in a context of shaming and alexithymia limits their access to psychiatric care. Child and adolescent psychiatrists then redefine the medical response to polymorphous symptoms. Psychiatric diagnoses mainly involve anxiety and depression symptoms, seldom eating disorders.    Conclusion: Physicians have overtly conflicting perspectives over the intensity of mental conditions. Non-psychiatrists, sensitive to perceived distress, seek to have it quickly appraised if they detect a significant suffering. Child and adolescent psychiatrists find appraisal complex to perform in the absence of means, interest, and/or experience. Improving screening requires training health professionals and using multidisciplinary assessment means. What is Known: • Mental health and eating disorders are contributing factors of obesity but their relationship remains complex between cause and consequence. • Mental health conditions and psychosocial suffering are the main complications among adolescents suffering from obesity with guilt, sadness, or stigma. What is New: • Non-psychiatric physicians express their need of a specialized diagnosis to define this suffering, but the lack of availability of psychiatrists and the necessity of time and of a multidisciplinary team lead to a delayed assessment. • For psychiatrists, this suffering is often not a psychiatric condition. Though requiring attention, this can lead to a misunderstanding between professionals.

[Siriade 2.0: An e-learning platform for radiation oncology contouring]. / Siriade 2.0 : outil de formation en ligne à la délinéation en radiothérapie.

PURPOSE: In 2008, the French national society of radiation oncology (SFRO) and the association for radiation oncology continued education (AFCOR) created Siriade, an e-learning website dedicated to contouring. MATERIAL AND METHODS: Between 2015 and 2017, this platform was updated using the latest digital online tools available. Two main sections were needed: a theoretical part and another section of online workshops. RESULTS: Teaching courses are available as online commented videos, available on demand. The practical section of the website is an online contouring workshop that automatically generates a report quantifying the quality of the user's delineation compared with the experts'. CONCLUSION: Siriade 2.0 is an innovating digital tool for radiation oncology initial and continuous education.

[Extra-uterine pelvic leiomyoma: diagnosis and practical management]. / Léiomyome pelvien extra-utérin: diagnostic et prise en charge.

OBJECTIVES: To analyze the possibilities of setting up a therapy for extra-uterine pelvic leiomyomas. METHODS: Three cases of leiomyomas of the broad ligament, of the round ligament and of the ovary, and literature review. RESULTS: Little is known about physiopathology of extra-uterine leiomyoma. The diagnosis of extra-uterine leiomyoma is based on histopathological analysis, using standard histology, and immunohistochemistry with anti-desmin and anti smooth muscle actin antibodies. The main differential diagnoses are fibroma, fibrothecoma, ovarian fibrosarcoma, and gastrointestinal stromal tumors. To define criteria of malignancy, we use Bell's classification without being sure that the uterine and extra-uterine models are comparable. So there is a risk of ignoring a low grade leiomyosarcoma. Providing therapy depends on the clinicopathologic features: the so called "parasitic leiomyoma", a tumor developed at the expense of local smooth muscle cells, metastasis of a benign metastasizing leiomyoma or leiomyomatosis peritonealis disseminata. CONCLUSION: The extra-uterine leiomyoma has no precise nosologic status and no specific criteria of benignity; thus no precise evolution can be predicted. We must be extremely careful, and the issue of the monitoring and long-term therapy of patients must come up.

[The EQUAL-ESTRO external quality control laboratory in France]. / Le laboratoire de contrôle de qualité externe EQUAL-ESTRO en France.

PURPOSE: The EQUAL-ESTRO laboratory was set up in 1998 to perform external audits of radiotherapy beams for all the European centres. Until the end of the year 2003, it was funded by EC projects. The external quality control is based on measurements performed with thermoluminescent dosimeters (TLD) sent by postal mail to the participating centre in order to be irradiated on axis in reference conditions and in conditions close to clinical conditions for photon and electron beams. The EQUAL-ESTRO laboratory also started in 2002, a new TLD control allowed to check the dosimetry of complex clinical fields for photon beams with multileaf collimator (MLC). New geometric and dosimetric checks have also been developed for brachytherapy. MATERIAL AND METHODS: The participating centre irradiates TLDs (7LiF: Na, mg, Ti, TLD 937 [Philitec]) in water at a dose of 2 Gy, calculated with the TPS used clinically, following the EQUAL-ESTRO protocol. RESULTS: Since the beginning of the activities, 46% of the French radiotherapy centres and 55% of the European radiotherapy centres applied to participate to the EQUAL quality control programme. In France, the EQUAL-ESTRO laboratory checked, from 1998 and June 2004, 283 photon beams, 180 electron beams and 61 photon beams with MLC. For all the French beams checks, the following results have been observed: for the photon beams, the results show that about 1% of the measured doses in the reference conditions on axis have been detected outside the tolerance level (deviation between the measured dose and the stated dose > +/- 5%) after a first or a second check. For points checked in photon beams with wedge filter, 2.5% of the beams checked show a deviation > +/- 5% after a first or a second check. For the electron beams, the check has been set up in January 1999. For the 180 electron beams checked, 5% of the measured doses in the reference conditions have been found outside the tolerance level (> +/- 5%). CONCLUSION: These results show clearly the importance of the quality control in radiotherapy in the frame of an external audit. This audit should now be a part of a quality assurance programme in the radiotherapy centres in addition to the internal quality control as planned in the French law (02/03/2004) concerning the external quality control conditions of the radiotherapy treatment units.